Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Generali $22 billion portfolio sale to private equity complicated by rate surge

Published 27/06/2023, 10:52
© Reuters. FILE PHOTO: The Generali logo is seen in Milan's CityLife district, Italy November 5, 2018.  REUTERS/Stefano Rellandini/File Photo
GS
-
GASI
-

By Pablo Mayo Cerqueiro, Amy-Jo Crowley and Gianluca Semeraro

LONDON/MILAN (Reuters) - Assicurazioni Generali (BIT:GASI)'s plans to shed up to 20 billion euros ($21.87 billion) of insurance liabilities are being hampered as a surge in interest rates has complicated talks with buyers, three people familiar with the matter said.

The Italian insurer embarked on a process late last year to sell a large batch of domestic life insurance contracts to free up capital.

It has been working with Goldman Sachs (NYSE:GS) to sound out buyers for the portfolio, including Portugal-based GamaLife, backed by Apax Partners, and Bermuda-based Athora, backed by Apollo Global Management, said the people, who spoke on condition of anonymity.

Spain-based MedVida, owned by U.S. billionaire Paul Singer's hedge fund Elliott Management, has also shown interest in the portfolio, which is made up of different clusters of policies, one of the people said.

But interest rate rises have added to the deal's complexity, raising questions over the value of the portfolio and the regulatory appetite to authorise such a large transfer of risk to buyout groups.

Generali may seek to revive discussions after agreeing to acquire Liberty Mutual's European operations earlier this month for 2.3 billion euros, which had taken much of the group's attention, one person said.

However, the insurer is open to alternative structures for outsourcing the risk, for example, through a reinsurance arrangement, another one added.

Generali, Goldman Sachs, Apax Partners, Athora and Elliott declined to comment. Spokespeople for Apollo, GamaLife and MedVida did not respond to a request for comment.

Back, closed or run-off insurance books consist of policies that are no longer sold to new customers but remain in force, requiring insurers to hold capital against future obligations.

Traditional insurance groups have been carving out these legacy portfolios to release the trapped capital and use it elsewhere.

Meanwhile, private equity funds have built consolidation platforms to acquire these unwanted policies and try to manage them better, for example, by using their asset management expertise to generate higher investment returns.

The escalation of interest rises across the Western world means maintaining old insurance savings contracts can become cheaper for insurers, as the relative yields they pay customers are reduced compared to other investments.

However, the change in the rate cycle has also prompted some policyholders, particularly in Italy, to withdraw their money early to invest in higher-yielding products, putting pressure on the sector and notably leading to the failure of Eurovita, a midsize insurer owned by buyout house Cinven.

© Reuters. FILE PHOTO: The Generali logo is seen in Milan's CityLife district, Italy November 5, 2018.  REUTERS/Stefano Rellandini/File Photo

While rating agencies consider Eurovita to be an outlier, the case has heightened regulatory scrutiny of the sector, leading to a slowdown in deal-making, the people said.

($1 = 0.9144 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.